Healthstream (HSTM) Cash & Equivalents (2010 - 2026)

Healthstream (HSTM) has reported Cash & Equivalents for 17 consecutive years, with $46.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 11.39% year-over-year to $46.2 million in Q2 2026; TTM through Jun 2026 was $46.2 million, a 11.39% decrease from a year earlier, with the FY2025 full-year figure at $36.2 million, down 39.19% from the prior year.
• Cash & Equivalents was $46.2 million for Q2 2026 at Healthstream, down from $48.7 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $77.3 million in Q1 2025 and troughed at $25.8 million in Q2 2023.
• A 5-year average of $48.0 million and a median of $47.2 million in 2022 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents jumped 78.77% in 2024 and slumped 39.19% in 2025, its largest moves.
• Over 5 years, Cash & Equivalents stood at $46.0 million in 2022, then dropped by 12.36% to $40.3 million in 2023, then jumped by 47.45% to $59.5 million in 2024, then tumbled by 39.19% to $36.2 million in 2025, then climbed by 27.68% to $46.2 million in 2026.
• The last three Cash & Equivalents figures came in at $46.2 million (Q2 2026), $48.7 million (Q1 2026), and $36.2 million (Q4 2025), per Business Quant data.